What did @drpatrickflynn actually say?
Flynn claims that tribulus works as "an LA stimulant" that prompts the brain to release luteinizing hormone (LH), which then tells the testes to produce testosterone. He adds that zinc is a necessary building block for the testosterone molecule itself, and that statin use might deplete cholesterol levels needed for production. He also shares that his own testosterone is "over 850" at age 40, implying these supplements are partly responsible.
He recommends oyster-derived zinc specifically, calling it the most bioavailable form and "the specific zinc you need to produce testosterone." The pitch ends with a direct link to his supplement store, which is the commercial context you should keep in mind when evaluating everything else he says.
Does the science back this up?
Partially, but the strongest claims here are significantly oversold. The zinc-testosterone connection has real evidence behind it, but tribulus is a different story. The LH-stimulating mechanism Flynn describes for tribulus sounds plausible, but the clinical data is weak and inconsistent.
On zinc: a well-cited study by Prasad et al. (1996, Nutrition) found that zinc restriction in healthy men reduced serum testosterone, and supplementation in zinc-deficient older men raised it. That is a real effect, but it applies specifically to men who are actually deficient. A 2011 study by te Velde and colleagues in the context of male fertility also confirmed zinc's enzymatic role in testosterone synthesis.
On tribulus: a 2014 randomized controlled trial by Roaiah et al. (Journal of Sex and Marital Therapy) found no significant change in testosterone levels in men taking tribulus terrestris. A 2020 review by Santos et al. (Phytotherapy Research) concluded that evidence for tribulus raising testosterone in humans is, at best, inconsistent, with most positive studies done in animals or using non-standardized extracts. The LH-stimulating claim Flynn makes lacks solid human clinical backing.
What did they get wrong (or right)?
Flynn gets credit for correctly identifying zinc as a cofactor in testosterone biosynthesis and for flagging statins as a potential issue. Statins do lower cholesterol, and cholesterol is the precursor to all steroid hormones including testosterone. That connection is legitimate and often underappreciated.
Where he goes wrong is the tribulus mechanism. Calling it "an LA stimulant" is not standard pharmacological terminology, and the claim that it reliably stimulates LH release in humans is not well supported. Flynn presents this as established fact, not as a hypothesis. That is a meaningful difference when you are selling a supplement stack.
The oyster zinc claim also deserves scrutiny. Oyster extract does contain zinc, and some data suggests good bioavailability, but the framing that it provides "the specific zinc you need to produce testosterone" implies a unique molecular form that does not exist. Zinc is zinc. Bioavailability differences between forms like zinc gluconate, zinc citrate, and oyster extract are modest and context-dependent.
Sharing his personal testosterone level as social proof is not science. It is marketing.
What should you actually know?
If you are a man with confirmed low testosterone, the first question is why. Supplementing zinc makes sense only if you are deficient, which is more common than most people realize, especially in men who sweat heavily, eat low meat diets, or take medications that impair absorption. A simple serum zinc test can tell you.
Tribulus terrestris is not a proven testosterone booster in healthy adult men. It may have effects on libido through non-androgenic pathways, but that is different from what Flynn is claiming. Spending money on tribulus based on this video's explanation is not well supported by evidence as of 2024.
If your testosterone is genuinely low, a conversation with a licensed clinician, not a supplement store link in an Instagram comment, is the appropriate next step. Actual hypogonadism requires diagnosis, not a stack. And no supplement has been shown to replicate the effects of clinically indicated testosterone replacement therapy for men with confirmed deficiency.